Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-25 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 625,00 | 499,03k | Derivative Exercise and Retained Stock | 798,45 | 8,90k | 7,55% |
| 2025-03-13 | Ms. Christina M. AckermannIndependent Director | 1,86k | 56,58k | Kauf | 30,45 | 5,12k | 56,92% |
| 2026-03-09 | Dr. Riad SherifCEO & Director | -25,00k | 867,65k | Verkauf | 33,06 - 36,24 | 1,29M | -1,91% |
| 2026-02-25 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 625,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,28k | 8,17% |
| 2026-02-13 | Mr. Anthony A. RosenbergIndependent Chairman | -5,07k | 0,00 | Other Disposition | - | 118,99k | -4,09% |
| 2026-02-13 | Ms. Sylvia CheungCFO | -3,51k | 0,00 | Other Disposition | - | 73,81k | -4,53% |
| 2026-02-13 | Dr. Riad SherifCEO & Director | -46,07k | 0,00 | Other Disposition | - | 1,03M | -4,27% |
| 2026-02-13 | Mr. Páll Ragnar JóhannessonChief Business Officer | -13,07k | 0,00 | Other Disposition | - | 255,76k | -4,86% |
| 2026-01-05 | Dr. Riad SherifCEO & Director | 12,30k | 0,00 | Derivative Exercise and Retained Stock | - | 1,08M | 1,15% |
| 2025-12-04 | Mr. Anthony A. RosenbergIndependent Chairman | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 124,06k | 2,70% |
| 2025-12-04 | Ms. Christina M. AckermannIndependent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 3,26k | - |
| 2025-12-04 | Mr. Robert K. WarnerIndependent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 6,53k | 100,00% |
| 2025-12-04 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 7,65k | 74,42% |
| 2025-11-29 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 1,89k | 0,00 | Derivative Exercise and Retained Stock | - | 4,39k | 75,44% |
| 2025-11-13 | Mr. Lionel CarnotIndependent Director | 15,00k | 289,18k | Kauf | 19,28 | 32,50k | 85,71% |
| 2025-10-09 | Ms. Christina M. AckermannIndependent Director | -7,46k | 156,75k | Verkauf | 21,01 | 0,00 | -100,00% |
| 2025-10-05 | Dr. Riad SherifCEO & Director | 12,30k | 0,00 | Derivative Exercise and Retained Stock | - | 1,07M | 1,17% |
| 2025-09-23 | Dr. Riad SherifCEO & Director | -25,00 | 450,00 | Verkauf | 18,00 | 1,05M | -0,00% |
| 2025-09-04 | Mr. Anthony A. RosenbergIndependent Chairman | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 120,80k | 2,78% |
| 2025-09-04 | Ms. Christina M. AckermannIndependent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 3,26k | - |
| 2025-09-04 | Mr. Robert K. WarnerIndependent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 3,26k | - |
| 2025-09-04 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 10,81k | 43,27% |
| 2025-08-29 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 1,89k | 0,00 | Derivative Exercise and Retained Stock | - | 7,54k | 33,33% |
| 2025-07-05 | Dr. Riad SherifCEO & Director | 12,30k | 0,00 | Derivative Exercise and Retained Stock | - | 1,05M | 1,18% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
